Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women between 20 and 70 years of age
- People newly diagnosed with a specific type of cervical cancer — either squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma
- People whose scans (CT or MRI, sometimes PET-CT) show enlarged lymph nodes in the pelvis or near the major abdominal blood vessels, meeting specific size measurements (confirm with trial site for exact details)
- People for whom doctors have planned a treatment combining chemotherapy and radiation therapy for cervical cancer
- People with a general health and activity level rated as 0 or 1 on a standard medical scale, meaning largely able to carry out daily activities without restriction
- People who have given written consent to take part in the study
- People for whom imaging scans have confirmed that surgery to remove affected lymph nodes would be possible
Who may not be able to join:
- People diagnosed with any other cancer (apart from thyroid cancer, and excluding very early-stage cancers) within the past 5 years
- People who are pregnant or plan to become pregnant during the study period
- People with an active infection or a severe ongoing inflammation that cannot be treated
- People whose health condition means doctors have determined surgery would not be safe for them
- People whose health condition means doctors have determined chemotherapy would not be safe for them
- People who have previously received radiation therapy to the pelvic area
- People who have previously had a partial (subtotal) hysterectomy
- People whose cancer has spread to distant areas of the body beyond the pelvic or abdominal lymph nodes — for example, to the lungs, or to lymph nodes near the collarbone or groin
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ju-Won Roh, CHA University Ilsan Medical Center
Phone: +82-31-782-8312
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.